The project’s objective is to make pharmacological treatment in outpatient care more precise, faster, and highly individualized. To achieve this, PersonMe integrates four key components:
-
Digital capture of individual health and therapy trajectories through app-based self-ratings (experience sampling) and sensor data, such as activity and movement patterns collected via smart devices,
-
Ambulatory therapeutic drug monitoring using capillary blood samples to measure psychotropic drugs and their metabolites,
-
Pharmacometric modeling to generate individualized dosing recommendations,
-
Development and operation of a secure, GDPR-compliant IT platform for the integration, processing, and provision of all collected data,
-
Development of a roadmap for sustainable integration of the system into routine healthcare.
All collected data are integrated, analyzed, and clinically evaluated within a secure and privacy-compliant IT platform. The goal is to provide treating physicians with an evidence-based decision support system that enables a significantly reduced “time to decision” in response to therapy fluctuations, thereby helping to prevent relapses, adverse effects, and hospitalizations.
Beyond technological innovation, PersonMe follows a consistently patient-centered approach: patients are actively involved in the monitoring process (“patient empowerment”), gaining greater transparency and a more active role in managing their own treatment.
The project is carried out by an interdisciplinary consortium consisting of:
-
Bioanalytik Münster e. V. (project coordination)
-
Department of Mental Health, University Hospital Münster
-
beemo GmbH (software development)
-
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster
Further information is available at: www.personme.de
Funded within the framework of the EFRE/JTF Programme NRW 2021–2027 (co-funded by the European Union and the State of North Rhine-Westphalia).